Holding Co Scilex serves as Executive at Semnur Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Holding Co Scilex has executed 16 insider transactions totaling $257.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 14, 2026 involved selling 5,115,586 shares valued at $3.7M.
Holding Co Scilex currently holds 213,766,229 shares of Semnur Pharmaceuticals, Inc. (SMNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holding Co Scilex has been a net seller of SMNR stock. They have purchased $0 and sold $257.9M worth of shares.
Holding Co Scilex's most recent insider trade was on Jan 14, 2026, when they sold 5,115,586 shares at $0.72 per share.
Get notified when new Form 4 filings are submitted
| $0.91 |
| Discretionary |
| Jan 12, 2026 | DVLT | $9.4M | Sale | 10,674,816 | $0.88 | Discretionary |
| Jan 8, 2026 | DVLT | $4.1M | Sale | 3,824,201 | $1.07 | Discretionary |
| Jan 7, 2026 | DVLT | $5.8M | Sale | 4,835,581 | $1.20 | Discretionary |
| Jan 6, 2026 | DVLT | $8.3M | Sale | 6,053,708 | $1.37 | Discretionary |
| Dec 30, 2025 | SCLX | $5.2M | Sale | 9,657,300 | $0.54 | Discretionary |
| Dec 30, 2025 | DVLT | $5.2M | Sale | 9,657,300 | $0.54 | Discretionary |
| Dec 29, 2025 | SCLX | $4.8M | Sale | 7,310,984 | $0.66 | Discretionary |
| Dec 29, 2025 | DVLT | $4.8M | Sale | 7,310,984 | $0.66 | Discretionary |
| Dec 26, 2025 | SCLX | $2.8M | Sale | 3,689,016 | $0.75 | Discretionary |
| Dec 26, 2025 | DVLT | $2.8M | Sale | 3,689,016 | $0.75 | Discretionary |
| Nov 28, 2025 | DVLT | $869.9K | Sale | 422,299 | $2.06 | Discretionary |
| Nov 25, 2025 | DVLT | $0 | Exercise | 263,914,094 | $N/A | Discretionary |
| Sep 23, 2025 | SMNR | $191.1M | Sale | 11,945,151 | $16.00 | Discretionary |
| Sep 23, 2025 | SMNR | $8.9M | Sale | 554,849 | $16.00 | Discretionary |